Document is current
Any future updates will be listed below
-
Authors
Kwon, Soonwook https://orcid.org/0000-0002-5578-7571
Kim, Bongseong https://orcid.org/0000-0002-1022-3553
Han, Kyung-Do https://orcid.org/0000-0002-6096-1263
Jung, Wonyoung https://orcid.org/0000-0003-4749-4637
Cho, Eun Bin https://orcid.org/0000-0003-2021-8587
Shin, Dong Wook https://orcid.org/0000-0001-8128-8920
Min, Ju-Hong https://orcid.org/0000-0002-7338-9067
-
Funding
Funding for this research was provided by:
Ministry of Health and Welfare (HI20C1073)
- License Information
-
More Information
Article History
Received: 10 October 2024
Accepted: 20 February 2025
First Online: 6 March 2025
Declarations
:
: This study was approved by the Institutional Review Board of Samsung Medical Center (File No. SMC-2020-12-108) and was performed in line with the principles of the Declaration of Helsinki.
: The review board waived the requirement for written informed consent because publicly open and anonymous data were used for the analysis and retrospective features.
: This study was conducted based on deidentified data of human participants.
: Ju-Hong Min has lectured, consulted, and received honoraria from Bayer Schering Pharma, Merck Serono, Biogen Idec, Sanofi Genzyme, Teva-Handok, UCB, Samsung Bioepis, Mitsubishi Tanabe Pharma, and Roche. Ju-Hong Min received a National Research Foundation of Korea grant and an SMC Research and Development Grant. The other authors report no disclosures relevant to the manuscript.
